Scott  Bluestein net worth and biography

Scott Bluestein Biography and Net Worth

Chief Executive Office and Chief Investment Officer of Hercules Capital
Scott Bluestein was named chief executive officer and president, and appointed to the board of directors and in July 2019. He was appointed chief investment officer in 2014, and continues to serve in that role today. He joined Hercules in 2010 as chief credit officer and brings more than 22 years of financial services, direct investment and credit experience to Hercules. Before joining Hercules, he served as founder and partner of Century Tree Capital Management, a fund established to make senior secured debt investments with warrants and equity co-investments in small and micro cap public and private companies. Prior to that, he was managing director at Laurus - Valens Capital Management, where he had responsibility for a structured debt with equity investment portfolio, including new investments, portfolio management, and restructurings. Previously, Bluestein worked at UBS Investment Bank, where he was a member of the Financial Technology Coverage Group. Bluestein received his B.B.A. in Finance from Emory University.

What is Scott Bluestein's net worth?

The estimated net worth of Scott Bluestein is at least $41.52 million as of September 26th, 2024. Mr. Bluestein owns 2,161,207 shares of Hercules Capital stock worth more than $41,516,786 as of December 21st. This net worth estimate does not reflect any other assets that Mr. Bluestein may own. Additionally, Mr. Bluestein receives a salary of $3,870,000.00 as Chief Executive Office and Chief Investment Officer at Hercules Capital. Learn More about Scott Bluestein's net worth.

How old is Scott Bluestein?

Mr. Bluestein is currently 46 years old. There are 6 older executives and no younger executives at Hercules Capital. Learn More on Scott Bluestein's age.

What is Scott Bluestein's salary?

As the Chief Executive Office and Chief Investment Officer of Hercules Capital, Inc., Mr. Bluestein earns $3,870,000.00 per year. Learn More on Scott Bluestein's salary.

How do I contact Scott Bluestein?

The corporate mailing address for Mr. Bluestein and other Hercules Capital executives is 400 HAMILTON AVE SUITE 310, PALO ALTO CA, 94301. Hercules Capital can also be reached via phone at (650) 289-3060 and via email at [email protected]. Learn More on Scott Bluestein's contact information.

Has Scott Bluestein been buying or selling shares of Hercules Capital?

Scott Bluestein has not been actively trading shares of Hercules Capital during the last quarter. Most recently, Scott Bluestein sold 100,000 shares of the business's stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $19.59, for a transaction totalling $1,959,000.00. Following the completion of the sale, the chief executive officer now directly owns 2,161,207 shares of the company's stock, valued at $42,338,045.13. Learn More on Scott Bluestein's trading history.

Who are Hercules Capital's active insiders?

Hercules Capital's insider roster includes Robert Badavas (Director), Scott Bluestein (Chief Executive Office and Chief Investment Officer), Gayle Crowell (Director), Thomas Fallon (Director), Christian Follmann (COO), Wade Loo (Director), and Nikos Theodosopoulos (Director). Learn More on Hercules Capital's active insiders.

Are insiders buying or selling shares of Hercules Capital?

In the last year, Hercules Capital insiders bought shares 2 times. They purchased a total of 2,310 shares worth more than $43,067.34. In the last year, insiders at the financial services provider sold shares 3 times. They sold a total of 115,000 shares worth more than $2,254,197.00. The most recent insider tranaction occured on September, 26th when CEO Scott Bluestein sold 100,000 shares worth more than $1,959,000.00. Insiders at Hercules Capital own 1.9% of the company. Learn More about insider trades at Hercules Capital.

Information on this page was last updated on 9/26/2024.

Scott Bluestein Insider Trading History at Hercules Capital

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/26/2024Sell100,000$19.59$1,959,000.002,161,207View SEC Filing Icon  
11/21/2022Sell100,000$14.16$1,416,000.00946,621View SEC Filing Icon  
3/18/2021Sell80,000$15.80$1,264,000.00923,086View SEC Filing Icon  
5/19/2015Sell6,000$12.65$75,900.00View SEC Filing Icon  
4/20/2015Sell6,000$13.90$83,400.00View SEC Filing Icon  
2/19/2015Sell6,000$15.36$92,160.00View SEC Filing Icon  
1/20/2015Sell6,000$13.96$83,760.00View SEC Filing Icon  
12/19/2014Sell6,000$14.81$88,860.00View SEC Filing Icon  
11/3/2014Sell6,000$15.84$95,040.00View SEC Filing Icon  
10/1/2014Sell6,000$14.33$85,980.00View SEC Filing Icon  
9/2/2014Sell6,000$15.25$91,500.00View SEC Filing Icon  
8/1/2014Sell6,000$16.55$99,300.00View SEC Filing Icon  
7/1/2014Sell6,000$16.21$97,260.00View SEC Filing Icon  
6/16/2014Sell6,000$15.50$93,000.00View SEC Filing Icon  
5/7/2014Sell17,733$14.24$252,517.92184,040View SEC Filing Icon  
See Full Table

Scott Bluestein Buying and Selling Activity at Hercules Capital

This chart shows Scott Bluestein's buying and selling at Hercules Capital by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hercules Capital Company Overview

Hercules Capital logo
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels, and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, drug platform, development, and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. Within sustainable and renewables, it invests in Vehicle Technology, Energy Generation and Storage, Ag Technology, Advanced Materials, and Industry 4.0. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest, particularly in the areas of software, biotech, and information services. The firm prefers to invest between $5 million and $200 million in equity per transactions. It invests generally between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in San Mateo, California with additional offices in North America and Europe.
Read More

Today's Range

Now: $19.21
Low: $18.98
High: $19.48

50 Day Range

MA: $19.40
Low: $18.53
High: $20.21

2 Week Range

Now: $19.21
Low: $16.15
High: $21.78

Volume

1,278,148 shs

Average Volume

949,421 shs

Market Capitalization

$3.12 billion

P/E Ratio

9.51

Dividend Yield

8.34%

Beta

1.36